Pulmonary Hypertension Trial, Recruiting NCT05903001 Sponsor: RWTH Aachen University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT05903001
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with one of these lung conditions: COPD, bronchial asthma, pulmonary fibrosis, or pulmonary hypertension
  • You are 18 years old or older
  • You are able to understand what the study involves and can follow the instructions given to you
  • You are legally able to make your own decisions
  • You are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • Your Body Mass Index (BMI) is over 35 (confirm with trial site if you are unsure of your BMI)
  • You have current or past medical conditions or treatments that could affect how the study results are measured (confirm with trial site)
  • You are unlikely to be willing to actively take part in all study-related activities
  • You currently have issues with alcohol or drug misuse
  • You have a slipped or herniated disc in your spine
  • You have epilepsy
  • You use a wheelchair as your main way of getting around
  • You are currently held in custody under an official or court order
  • You have a close personal or work relationship with the doctor leading the study or their deputies
  • You had an unplanned hospital stay in the 4 weeks before the study examinations begin

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Dreher, MD, Uniklinik RWTH Aachen

Phone: 0049 2418037036

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
RWTH Aachen University
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
30 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Dyspnea Borg scale 1 to 10; Dyspnea Borg scale 1 to 10; Dyspnea Borg scale 1 to 10; Dyspnea Borg scale 1 to 10; Dyspnea Borg scale 1 to 10

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov